We invite patients with mild bronchial asthma to participate in the study of the treatment of asthma of physical effort. During each of the four visits to the study site, a physical exercise test and a series of studies of the function of external respiration will be conducted.

Our site has been selected to participate in the study of a new medicine for the treatment of fungal nail lesions. Patients will be monitored for about a year and will receive not only the most modern treatment, but also regular medical pedicure.

Researchers from the OLLA-MED LLC center took part in the national congress dedicated to the diagnosis and treatment of respiratory diseases. During the congress, colleagues exchanged experience on a wide range of interdisciplinary problems and outlined ways for further cooperation.

Recruitment of patients who have had pulmonary tuberculosis into a clinical trial of the GamTBVac vaccine has begun to evaluate the effectiveness of the vaccine in preventing relapse. Remuneration for participation in the study is possible. Write to us 8 (993) 202 7840 (whatsapp).

Our partners

Protagonist
Gilead
Mithra
PRA Health Sciences
Pfizer
Rusmo-AG
Sanofi
Abbvie
Icon
Astra Zeneca
Gedeon Richter
Cromos Pharma
PPD
X7 Research
Synteract
IQVIA
Biorasi | Built for Faster Clinical Trials
PSI
ALK
Galecto
SRG
Clinipas
Astellas
Janssen
JonsonAndJonson
OCT
Celgen
Bristol-Myers Squibb Company
Biogen